Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca2+/Mn2+-ATPase isoform 1 in patients with non-desmoglein pemphigus vulgaris-Reference-Cited by-同舟云学术

Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca2+/Mn2+-ATPase isoform 1 in patients with non-desmoglein pemphigus vulgaris

Published:2020-03 Issue: Volume:80 Page:106149
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Chernyavsky Alex,Patel Krupa G.,Grando Sergei A.

Funder

Department of Dermatology, University of California-Irvine School of Medicine

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference50 articles.

1. Monopathogenic vs. multipathogenic explanations of pemphigus pathophysiology;Ahmed;Exp. Dermatol.,2016

2. Immune response in pemphigus and beyond: progresses and emerging concepts;Di Zenzo;Semin. Immunopathol.,2016

3. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris;Sharma;Int. J. Dermatol.,2006

4. Laboratory diagnosis of pemphigus: direct immunofluorescence remains the gold standard;Giurdanella;Br. J. Dermatol.,2016

5. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris;Jamora;J. Am. Acad. Dermatol.,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatment;British Journal of Dermatology;2024-03-20

2. The Role of Non-Neuronal Acetylcholine in the Autoimmune Blistering Disease Pemphigus Vulgaris;Biology;2023-02-23

3. The M3 Muscarinic Acetylcholine Receptor Promotes Epidermal Differentiation;Journal of Investigative Dermatology;2022-12

4. Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris;Antibodies;2022-08-25

5. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?;Cells;2022-03-10